Author

Paulo Rocha França Neto

Observed names: FRANÇA NETO, PAULO ROCHA, P. R. França Neto, P. R. França-Neto, P. R.F. Neto, P. Rocha Franca Neto, PAULO ROCHA FRANÇA NETO, Paulo França Neto, Paulo Rocha Franca, Paulo Rocha Franca Neto, Paulo Rocha França, Paulo Rocha França-Neto, Paulo Rocha Neto
ORCID: 0000-0001-6945-3401
Observed ORCID: 0000-0001-6945-3401
OpenAlex ID: A5065301436
2021 · F. E. F. Rabelo, A. Lacerda-Filho, et al. · Techniques in Coloproctology · 17
2011 · Paulo Rocha França Neto, Rodrigo de Almeida Paiva, et al. · Journal of Coloproctology · 9
2010 · Fábio Lopes de Queiroz, Marcelo Giusti Werneck Côrtes, et al. · Revista Brasileira de Coloproctologia · 7
2013 · Paulo Rocha França Neto, Fábio Lopes de Queiroz, et al. · Journal of Coloproctology · 6
2023 · JAIRO SEBASTIÁN ASTUDILLO VALLEJO, FABIO LOPES DE QUEIROZ, et al. · Revista do Colégio Brasileiro de Cirurgiões · 4
2023 · Daniel Mauricio Londoño Estrada, Fábio Lopes de Queiroz, et al. · International Journal of Colorectal Disease · 3
2016 · Felipe da Mota, Thalles Lisboa, et al. · Endoscopy · 3
2011 · Breno Xaia Martins da Costa, Fábio Lopes de Queiroz, et al. · Journal of Coloproctology · 2
2011 · Paulo Rocha França Neto, Leandro Alves Gomes Ramos, et al. · Revista Brasileira de Coloproctologia · 2
2023 · THAIS ANDRESSA SILVA FAIER, FABIO LOPES QUEIROZ, et al. · Revista do Colégio Brasileiro de Cirurgiões · 1
2023 · RODRIGO ALMEIDA PAIVA, FABIO LOPES QUEIROZ, et al. · Revista do Colégio Brasileiro de Cirurgiões · 1
Submit Manuscript | http://medc rav eonline.co m Introduction Colorectal adenocarcinoma is the third most common malignant neoplasia and the third leading cause of death from cancer in men and women in the United States. Current data show that the incidence of colorectal adenocarcinoma is decreasing in developed countries but increasing in developing countries. 1 The 2018 estimates of the Bra - zilian National Cancer Institute (Instituto Nacional do Câncer–INCA) were 17,380 new cases in men and 18,980 in women, making col - orectal adenocarcinoma the third most common neoplasia in men and the second most common in women in Brazil. 2 In the past 15 years, rectal cancer management has evolved in several aspects. Specifical - ly, a better understanding of the natural history of the disease, more precise radiological staging, multimodal therapeutic intervention, refined surgical techniques, and more detailed histopathological re - ports may have positively influenced patient survival. In this context, multidisciplinary management of colorectal cancer plays an important role and requires the coordinated teamwork of colorectal surgeons, oncologists, radiologists, and radiotherapists. 3 Total mesorectal exci - sion is still the basis of treatment in rectal cancer. However, neoadju - vant therapy and more conservative practices have been adopted in cases of clinical/pathological responses to radiochemotherapy. 4 Ra - diological evaluation of the response is of paramount importance for the selection of patients eligible for alternative treatment strategies, including ‘watch-and-wait’. Diffusion-weighted imaging is already being used routinely in the evaluation of the pathological response of rectal tumour patients submitted to neoadjuvant therapy. Some re - searchers have tried to estimate the tumour regression grade (TRG) using magnetic resonance imaging, as has been described for post-ra - diochemotherapy pathological evaluation, thus rendering it a valuable instrument. Considering the good results obtained with multimodal therapy in extraperitoneal rectal cancer, the evaluation of the pathological re - sponse post-neoadjuvant therapy must be considered as a factor for safe indication, both for the conservative option, in which the organ is preserved, and for radical surgical resection, influencing the choice between sphincter-preserving surgery and abdominoperineal excision. A precise evaluation, by comparing the results of post-neoadjuvant therapy magnetic resonance imaging with those obtained from his - Int J Radiol Radiat Ther. 2018;5(4):254 ‒ 258. 254 © 2018 Oliveira et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially. Magnetic resonance imaging is effective in assessing tumour regression after neoadjuvancy in rectal adenocarcinoma
2018 · Fábio Henrique de Oliveira, Antônio Lacerda-Filho, et al. · International Journal of Radiology & Radiation Therapy · 1
2026 · Daniel Mauricio Londoño Estrada, Marco Rinoldi, et al. · International Journal of Colorectal Disease
2025 · Fabio Lopes de Queiroz, Marco Rinoldi, et al. · Journal of Coloproctology
2025 · Cristiane Koizimi Martos Fernandes, Marco Rinoldi, et al. · Journal of Coloproctology
2025 · Fabio Lopes de Queiroz, Marco Rinoldi, et al. · Journal of Coloproctology
2024 · Marina Barbabela Grisolia de Oliveira, Fabio Lopes Queiroz, et al. · Journal of Coloproctology
2023 · Letícia Brandão Castro, Fábio Lopes de Queiroz, et al. · Journal of Coloproctology
2023 · Marina Barbabela Grisolia de Oliveira, Daniel Mauricio Lodoño Estrada, et al. · Journal of Coloproctology
2023 · Barbara Maria Tavares Pereira, Thais Andressa Silva Faier, et al. · Journal of Coloproctology
Works count: 56
Citation count: 59
H-index: 4
I10-index: 1
Year
Topic
Type